Brain Arteriovenous Malformations (AVMs) Development and Management

Epidemiology and Natural History

An estimated 20% of cerebral AVMs are diagnosed during infancy and childhood, with the remainder being detected in adulthood 1
The annual AVM detection rate across all ages is approximately 1.34 per 100,000 person-years 1
First-time AVM-related hemorrhage incidence is 0.51 per 100,000 person-years 1
The annual risk of hemorrhage for previously unruptured AVMs is approximately 2-3% per year 2, 3

AVMs can remain clinically silent for decades before becoming symptomatic 2
The most common initial presentation of AVMs across all age groups is hemorrhage (50-60% of cases) 2, 3
Children often present with hemorrhage (>75% of symptomatic pediatric cases) 1
Adults commonly present with seizures (20-25% of cases) or headaches (15% of cases) 3

Prior hemorrhage is a strong predictor of future hemorrhage 3
Small AVM size may paradoxically be associated with higher hemorrhage risk 3
The presence of intranidal aneurysms increases hemorrhage risk 4
The lifetime risk of hemorrhage can be approximated by: Lifetime risk (%) = 105 - (patient's age in years) 3

The risk of recurrent hemorrhage is elevated in the first year after initial hemorrhage (6-32.9% depending on the study) 3
Mortality from first hemorrhage ranges between 10-30%, with 10-20% of survivors experiencing long-term disability 3
Comprehensive evaluation requires both MRI and cerebral angiography to properly delineate AVM anatomy 4
Treatment decisions should weigh the natural history risk against intervention-related morbidity and mortality 3, 4

Treatment options include surgical excision, endovascular embolization, or stereotactic radiosurgery 4
The Spetzler-Martin grading system helps estimate surgical risks based on size, location, and venous drainage patterns 4
Regular monitoring is essential for stable AVMs to detect any changes in size or characteristics 4